Press Releases

Home / Investor Relations / Press Releases

Language

Category

Year

2019-05-06 21:01 Bulletin from Annual General Meeting in Boule Diagnostics AB on May 6, 2019

The Annual General Meeting (the ”AGM”) decided to adopt the balance sheet, income statement, consolidated income statement and consolidated balance sheet for 2018. Furthermore, it was decided that a dividend of SEK 0.55 per share will be distributed...

2019-05-06 15:01 Boule Diagnostics AB (publ) Interim report January–March 2019 Regulatory

2019 starts off with a strong growth in sales Significant events during the quarter No significant events occured in the first quarter 2019. Significant events after the period The company has conducted a review and assessment of accounts receivables...

2019-05-02 15:00 Boule Diagnostics – Q1 2019 presentation

Boule Diagnostics AB will publish the interim report for the period January – March 2019 at 15:00, Monday May 6, 2019. Following the publication, Boule will hold a conference call at 16:00 for media and investors. CEO Fredrik Dalborg and CFO Christina...

2019-04-15 10:01 Boule Diagnostics publishes the annual report for 2018 Regulatory

Boule Diagnostics AB has published the full annual report for the fiscal year 2018 at www.boule.com. The annual report is available in Swedish below. The annual report will also be made available in English at www.boule.com prior to the Annual General...

2019-02-07 15:01 Boule Diagnostics AB (publ) Year-end report January – December 2018 Regulatory

Good sales of instruments, product and geographic mix resulted in low margins Warning letter received from the FDA Following a routine inspection of Boule’s Swedish instrument manufacturing site in May 2018, Boule received inspectional observations...

2019-02-05 15:01 Boule Diagnostics – Q4 2018 presentation

Boule Diagnostics AB will publish the year-end report for the period January – December 2018 at 15:00, Thursday February 7, 2019. Following the publication, Boule will hold a conference call at 16:00 for media and investors. CEO Fredrik Dalborg and...

2018-12-18 15:01 Boule Diagnostics – Information regarding the investment in the strategic near patient diagnostics partnership

Boule Diagnostics AB will hold a conference call to inform about the strategic partnership Boule has entered with the diagnostics company, biosurfit. CEO Fredrik Dalborg and CFO Christina Rubenhag will present the information and answer questions. The...

2018-12-14 15:16 Boule Diagnostics invests in strategic near patient diagnostics partnership Regulatory

Boule has entered a strategic partnership, investing EUR 5 million in the diagnostic company biosurfit. The partnership is in alignment with the established strategy to broaden the product portfolio. biosurfit, a Portugal-based company, develops and manufactures...

2018-11-06 15:03 Boule Diagnostics AB (publ) Interim report January – September 2018 Regulatory

All-time high in number of delivered systems and net sales for an individual quarter Boule secured major tender in India In July, Boule secured a major tender in India, including 650 instruments, associated reagents and controls. Deliveries started...

2018-11-01 12:01 Boule Diagnostics – Q3 2018 presentation

Boule Diagnostics AB will publish the interim report for the period January – September 2018 at 15:00, Tuesday, November 6. Following the publication, Boule will hold a conference call at 16:00 for media and investors. CEO Fredrik Dalborg and CFO Christina...

2018-10-30 12:01 Boule Diagnostics – Nomination Committee for the 2019 Annual General Meeting

The Annual General Meeting, (”AGM”), 2018 of Boule Diagnostics AB (publ), (”Boule”), decided that a Nomination Committee based on the ownership structure as per September 30, 2018, will be appointed to propose for the AGM of 2019 the following...

2018-10-08 11:15 Boule Diagnostics – Information regarding received warning letter from US FDA

Boule Diagnostics AB will hold a conference call to inform about the warning letter Boule have received from FDA. CEO Fredrik Dalborg and CFO Christina Rubenhag will inform and reply to questions. The presentation will be held in English. Time: ...

2018-10-05 19:16 Boule Diagnostics receives US FDA warning letter Regulatory

Boule Medical (a Boule Diagnostics subsidiary) has today received a warning letter from the US FDA (Food and Drug Administration). After a routine inspection at the Boule instrument manufacturing site in Sweden in May 2018, Boule Diagnostics received...

2018-09-21 08:31 Boule Diagnostics streamlines production

The Boule Diagnostics Group is implementing a cost-reduction in instrument manufacturing, which is expected to provide an annual cost-saving of approximately SEK 3 million, beginning in the first quarter of 2019. The cost reduction is achieved through...

2018-08-15 15:01 Boule Diagnostics AB (publ) Interim report January – June 2018 Regulatory

Continued strong profitability improvements and good growth In April, Boule acquired new technologies in the field of laser optics that will be adapted to Boule’s requirements and be used in combination with internally developed technologies for the...

2018-08-13 16:01 Boule Diagnostics – Q2 2018 presentation

Boule Diagnostics AB will publish the interim report for the period January – June 2018 at 15:00, Wednesday, August 15. Following the publication, Boule will hold a conference call at 16:00 for media and investors. CEO Fredrik Dalborg and CFO Christina...

2018-08-07 15:16 Boule Diagnostics secured major tender in India Regulatory

A major tender has been secured in India, including a large number of instruments as well as reagents and controls. This complex tender process has been ongoing for an extended period of time and has been brought to a successful conclusion for Boule by...

2018-06-29 08:46 Boule Diagnostics – Change in number of shares and votes

In accordance with the decision of Boule Diagnostics AB's (publ) ("Boule") Annual General Meeting on May 14, 2018, a division of Boule’s shares has been implemented, whereby each existing share was divided into four (4) shares (so-called share split...

2018-06-01 08:46 Boule Diagnostics – First day for trading after the division of shares (stock split 4:1)

At the Annual General Meeting (”AGM”) of Boule Diagnostics AB (”Boule”) on May 14, 2018 it was decided that a division of Boule’s shares will be implemented, whereby each current share will be divided into four shares (so called stock split...

2018-05-15 08:46 Boule Diagnostics – Information on the decided division of shares (stock split 4:1)

In accordance with the decision made on the Annual General Meeting (“AGM”) of Boule Diagnostics AB (”Boule”) on May 14, 2018, a division of Boule’s shares will be implemented, whereby each existing share will be divided into four shares (so...

Previous Next